GLOBAL METABOLOMICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL METABOLOMICS MARKET FORECAST 2019-2027

GLOBAL METABOLOMICS MARKET FORECAST 2019-2027

The global metabolomics market is anticipated to grow at a CAGR of 11.84% between 2019 and 2027. Metabolomics is a study and analysis of biochemical processes involving intermediates and products of metabolic activity.The important drivers increasing growth in the global metabolomics market are the increasing investments in the metabolomics domain by the public and private sectors, and the rising demand for personalized medicines. The usages of new technologies like metabolomics, in reviewing cancer is promising, as it will disclose new biomarkers related to cancer. These biomarkers are found to be used in the diagnosis and prognosis of the diseases. The personalized medicines have become an integral part of focused treatment, making them a vital part of the pharmaceutical and biotech industry.

GLOBAL METABOLOMICS MARKET FORECAST 2019-2027

Request free sample

The global metabolomics market is anticipated to grow at a CAGR of 11.84% between 2019 and 2027. Metabolomics is a study and analysis of biochemical processes involving intermediates and products of metabolic activity.

The metabolomics market is primarily driven by the following factors:

  • Growing investments in the metabolomics domain by both, public and private sectors
  • A rise in the demand for personalized medicines
  • An upsurge in the incidences of chronic disease

The important drivers increasing growth in the global metabolomics market are the increasing investments in the metabolomics domain by the public and private sectors, and the rising demand for personalized medicines. The usages of new technologies like metabolomics, in reviewing cancer is promising, as it will disclose new biomarkers related to cancer. These biomarkers are found to be used in the diagnosis and prognosis of the diseases. The personalized medicines have become an integral part of focused treatment, making them a vital part of the pharmaceutical and biotech industry.

The products & services, as well as the applications of the metabolomics market, are used extensively for various purposes. The application of sophisticated analytical instruments is  utilized to study the metabolite composition of biological samples. The high-performance liquid chromatography (HPLC) accounted for the largest market share in the separation technique, and is anticipated to continue this trend in the study period. In gas chromatography, the state of the sample is in a gaseous state, which is carried out in a column packed with sample particles. The ultra-performance liquid chromatography (UPLC) works on the same principle as HPLC, but with improved efficiency. In capillary electrophoresis, ionic species are separated by their charge and frictional forces. The detection techniques for the metabolomics market are studied across surface-based mass analysis, nuclear magnetic resonance spectroscopy, and mass spectrometry (MS). The bioinformatics tools & services of metabolomics are categorized into bioinformatics tools & database and bioinformatics services. The biomarker is a quantifiable indicator of a consequential biological condition. It is also called as a biological marker. Drug discovery involves a wide range of analytical processes by which new prospective medications are discovered. Toxicity testing is used during clinical trials, where the toxicity of the compounds present in the test product is evaluated. Nutrigenomics is a science dealing with the certain field of human nutrition that employs molecular tools to analyze various responses gained through a particular diet applied between individual and population groups. Functional genomics often involves high-throughput methods concentrating on gene transcription, translation, and protein interaction.

The lack of skilled professionals in metabolomics, and the high cost of the instruments are the major factors hindering the prospects of the global metabolomics market. The data generated, using metabolomics requires skilled employees trained in this field to understand the outcomes logically. So, the lack of skilled personnel has created an imbalance between the investments being made on developing metabolomics, and the data that is being generated. There are high costs and efforts involved in the analysis of samples by a standard metabolomics workflow.

The global metabolomics market segments include products & services, applications, and indications.

Products & Services are segmented into:

  • Metabolomics instruments
    • Separation technique
      • High-performance liquid chromatography
      • Gas chromatography
      • Ultra-performance liquid chromatography
      • Capillary electrophoresis
    • Detection technique
      • Mass spectrometry
      • Nuclear magnetic resonance spectroscopy
      • Surface-based mass analysis
  • Metabolomics bioinformatics tools and services

Applications are segmented into:

  • Personalized medicine
  • Drug discovery
  • Biomarker discovery
  • Toxicology testing
  • Nutrigenomics
  • Functional genomics
  • Other application

Indications are segmented into:

  • Cancer
  • Neurological disorders
  • Inborn errors of metabolism
  • Cardiovascular disorders
  • Other indication

This report covers the present market conditions and the growth prospects of the global metabolomics market trends for 2019-2027, and considered the revenue generated through the sales of metabolomics for products & services, applications, and indications to calculate the market size by considering 2018 as the base year.

The metabolomics market by region has been segmented on the basis of four major regions, which include:

  • North America: The United States & Canada
  • Asia-Pacific: China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific
  • Europe: The United Kingdom, France, Germany, Italy, Spain, and the Rest of Europe
  • Rest of World: Latin America, the Middle East, and Africa

The metabolomics market in North America is expected to hold the largest share by 2027, possibilities of increased use of metabolomics. The North America Metabolomics market constitutes approx. 41% share. The region has a wide presence of different hospitals, specialty clinics, and research centers, which focus on studies and treatment related to chronic diseases. Several manufacturers in North America have made innovations in the field of metabolomics. On the other hand, the Asia-Pacific market region is anticipated to the fastest-growing region for the metabolomics market. Asia-Pacific covers a huge geographic area and contains economically diverse countries, from highly developed countries, like  Japan and South Korea, to highly developing countries like India and China. In Japan, the government is focusing more on the development of precision medicine with the help of genomic drug discoveries. Australia has well-established infrastructure facilities in regions, like New South Wales, Victoria, and Queensland. In several other areas, accessibility to high-end technology is increasing.

Cancer research and diagnostics are one of the major fields in the healthcare industry. Despite innumerable technological breakthroughs and contributions, there is still a lot to be uncovered about this threatening disease. Cardiovascular disorders are a type of disease related to blood vessels and heart. Neurology is a focused approach for the treatment of disorders related to the central nervous system. The inherited (genetic) and rare disorders and diseases that disrupt normal metabolism and the process of conversion of food to energy on a cellular level are termed as metabolic diseases. All these indications are anticipated to drive the metabolomics market growth.

The major market players of the metabolomics market are:

  • DANAHER CORPORATION
  • AGILENT TECHNOLOGIES
  • WATERS CORPORATION
  • THERMO FISHER SCIENTIFIC
  • SHIMADZU CORPORATION

Company Profiles covers an analysis of important players. SCIEX is the subsidiary of Danaher Corporation, having a wide range of products serving the Life Sciences market. Danaher Corporation is a global conglomerate, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. Shimadzu makes a wide variety of laboratory instruments (gas and liquid chromatography, mass spectrometers), medical systems (ultrasound, X-ray, fluoroscopy), testing and inspection instruments, surface analyzers, scales, aircraft equipment (flight control and landing gear systems), and industrial manufacturing equipment (deposition systems, LCD injection systems, turbomolecular pumps).

Key findings of the metabolomics market:

  • Metabolomics bioinformatics tools and services are the fastest-growing product & service.
  • Biomarker discovery is the most widely used application.
  • Cancer is the most prevalent indicator.
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
      • BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
      • CANCER IS THE MOST PREVALENT INDICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
      • RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
      • UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE
    • MARKET RESTRAINTS
      • LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
      • HIGH COST OF THE INSTRUMENTS
    • MARKET OPPORTUNITIES
      • EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
      • GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES
    • MARKET CHALLENGES
      • COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
        • HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
        • GAS CHROMATOGRAPHY
        • ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY
        • CAPILLARY ELECTROPHORESIS
      • DETECTION TECHNIQUE
        • MASS SPECTROMETRY
        • NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
        • SURFACE-BASED MASS ANALYSIS
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  1. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  2. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA-PACIFIC
      • JAPAN
      • CHINA
      • AUSTRALIA
      • INDIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES, INC.
      • APICAL SCIENTIFIC SDN BHD
      • BIOCRATES LIFE SCIENCES AG
      • BIO-RAD LABORATORIES, INC.
      • BRUKER CORPORATION
      • CREATIVE PROTEOMICS
      • DANAHER CORPORATION (SCIEX)
      • HUMAN METABOLOME TECHNOLOGIES, INC.
      • KORE TECHNOLOGY LIMITED
      • LECO CORPORATION
      • METABOLON INC.
      • PERKINELMER, INC.
      • SHIMADZU CORPORATION
      • THERMO FISHER SCIENTIFIC INC.
      • WATERS CORPORATION

LIST OF TABLES

TABLE 1: GLOBAL METABOLOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 2: GLOBAL METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 3: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 4: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 5: GLOBAL SEPARATION TECHNIQUE MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 6: GLOBAL DETECTION TECHNIQUE MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 7: GLOBAL METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 8: GLOBAL METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 9: GLOBAL BIOMARKER DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 10: GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 11: GLOBAL TOXICOLOGY TESTING MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 12: GLOBAL NUTRIGENOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 13: GLOBAL FUNCTIONAL GENOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 14: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 15: GLOBAL OTHER APPLICATION MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 16: GLOBAL METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 17: GLOBAL CANCER MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 18: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 19: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 20: GLOBAL INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 21: GLOBAL OTHER INDICATION MARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 22: GLOBAL METABOLOMICSMARKET, BY REGION, 2019-2027 ($ MILLION)

TABLE 23: NORTH AMERICA METABOLOMICSMARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 24: THE UNITED STATES METABOLOMICSMARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 25: THE UNITED STATES METABOLOMICSMARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 26: THE UNITED STATES METABOLOMICSMARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 27: CANADA METABOLOMICSMARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 28: CANADA METABOLOMICSMARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 29: CANADA METABOLOMICSMARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 30: EUROPE METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 31: GERMANY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 32: GERMANY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 33: GERMANY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 34: FRANCE METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 35: FRANCE METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 36: FRANCE METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 37: THE UNITED KINGDOM METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 38: THE UNITED KINGDOM METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 39: THE UNITED KINGDOM METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 40: ITALY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 41: ITALY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 42: ITALY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 43: SPAIN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 44: SPAIN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 45: SPAIN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 46: ASIA-PACIFIC METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 47: JAPAN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 48: JAPAN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 49: JAPAN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 50: CHINA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 51: CHINA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 52: CHINA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 53: AUSTRALIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 54: AUSTRALIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 55: AUSTRALIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 56: INDIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 57: INDIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 58: INDIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 59: SOUTH KOREA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 60: SOUTH KOREA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 61: SOUTH KOREA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 62: REST OF WORLD METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 63: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

 

LIST OF FIGURES

FIGURE 1: GLOBAL METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 2: GLOBAL METAGENOMICS MARKET SHARE, BY PRODUCT & SERVICE, 2018 & 2027 (%)

FIGURE 3: GLOBAL METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)

FIGURE 4: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 5: GLOBAL SEPARATION TECHNIQUE MARKET, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, 2019-2027 ($ MILLION)

FIGURE 6: GLOBAL SEPARATION TECHNIQUE MARKET, BY GAS CHROMATOGRAPHY, 2019-2027 ($ MILLION)

FIGURE 7: GLOBAL SEPARATION TECHNIQUE MARKET, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, 2019-2027 ($ MILLION)

FIGURE 8: GLOBAL SEPARATION TECHNIQUE MARKET, BY CAPILLARY ELECTROPHORESIS, 2019-2027 ($ MILLION)

FIGURE 9: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 10: GLOBAL DETECTION TECHNIQUE MARKET, BY MASS SPECTROMETRY, 2019-2027 ($ MILLION)

FIGURE 11: GLOBAL DETECTION TECHNIQUE MARKET, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2019-2027 ($ MILLION)

FIGURE 12: GLOBAL DETECTION TECHNIQUE MARKET, BY SURFACE-BASED MASS ANALYSIS, 2019-2027 ($ MILLION)

FIGURE 13: GLOBAL METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)

FIGURE 14: GLOBAL METABOLOMICS MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)

FIGURE 15: GLOBAL METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 16: GLOBAL METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 17: GLOBAL METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)

FIGURE 18: GLOBAL METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)

FIGURE 19: GLOBAL METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)

FIGURE 20: GLOBAL METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)

FIGURE 21: GLOBAL METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)

FIGURE 22: GLOBAL METABOLOMICS MARKET SHARE, BY INDICATION, 2018 & 2027 (%)

FIGURE 23: GLOBAL METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)

FIGURE 24: GLOBAL METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)

FIGURE 25: GLOBAL METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)

FIGURE 26: GLOBAL METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)

FIGURE 27: GLOBAL METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)

FIGURE 28: PORTER’S FIVE FORCE MODEL

FIGURE 29: GLOBAL METABOLOMICSMARKET, REGIONAL OUTLOOK, 2018 & 2027 (%)

FIGURE 30: THE UNITED STATES METABOLOMICSMARKET, 2019-2027 ($ MILLION)

FIGURE 31: CANADA METABOLOMICSMARKET, 2019-2027 ($ MILLION)

FIGURE 32: GERMANY METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 33: FRANCE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 34: THE UNITED KINGDOM METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 35: ITALY METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 36: SPAIN METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 37: REST OF EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 38: JAPAN METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 39: CHINA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 40: AUSTRALIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 41: INDIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 42: SOUTH KOREA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 43: REST OF ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 44: LATIN AMERICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 45: MIDDLE EAST AND AFRICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
        • HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
        • GAS CHROMATOGRAPHY
        • ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY
        • CAPILLARY ELECTROPHORESIS
      • DETECTION TECHNIQUE
        • MASS SPECTROMETRY
        • NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
        • SURFACE-BASED MASS ANALYSIS
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  1. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  2. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA-PACIFIC
      • JAPAN
      • CHINA
      • AUSTRALIA
      • INDIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now